Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.60
Ask:
203.00
Spread: 0.40 (0.197%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Q2 AuM Statement

14 Jan 2014 07:00

RNS Number : 5534X
Ashmore Group PLC
14 January 2014
 



Ashmore Group plc

+0700 14 January, 2014

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist emerging markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2013.

Assets under Management

Theme

Actual30 September 2013

(US$ billion)

Estimated31 December 2013

(US$ billion)

Movement

Q2 vs Q1(%)

External debt

13.8

13.4

-2.9

Local currency

17.2

16.9

-1.7

Corporate debt

6.4

7.0

+9.4

Blended debt

19.7

19.1

-3.0

Equities

5.7

5.3

-7.0

Alternatives

2.9

2.5

-13.8

Multi-strategy

3.3

2.8

-15.2

Overlay / liquidity

9.5

8.3

-12.6

Total

78.5

75.3

-4.1

 

Assets under management declined during the quarter to US$75.3 billion as a result of net outflows totalling US$3.5 billion and positive investment performance of US$0.3 billion.

The majority of the net outflow resulted from a small number of redemptions from segregated mandates in the blended debt and overlay / liquidity themes. The external debt, equities and multi-strategy themes also experienced net outflows, and alternatives funds returned capital as expected during the quarter. Corporate debt saw a net inflow.

There were modest positive contributions to investment performance in equities, external debt, corporate debt, and blended debt, offset by mildly negative performance in local currency, alternatives and overlay/liquidity.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Market performance and, to some extent, investor behaviour during the quarter continued to be influenced by uncertainty surrounding US monetary policy and the heightened market volatility experienced since early May last year. There is now greater clarity over US monetary policy, and Emerging Market assets offer attractive prospective returns across both equities and fixed income, and especially against Developed Market assets. This continues to give us confidence for the year ahead."

During the quarter, the basis of calculation for the annual investment management fee on two of the Group's closed end special situations funds was amended from 2% of acquisition cost to the lower of 2% of acquisition cost and 2% of net asset value. The amended management fee arrangements applied from 1 October 2013, and the pro forma annualised effect is to reduce revenues from the alternatives theme by US$25 million.

For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.6557 at 31 December 2013, a 9% appreciation since 30 June 2013 (1.5213). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the first half of the year was 1.5868 (H1 2012/13: 1.5974).

Ashmore will announce its interim results in respect of the six months ended 31 December 2013 on 25 February 2014.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI Consulting - PR to Ashmore Group plcAndrew Walton +44 (0)20 7269 7204Paul Marriott +44 (0)20 7269 7252

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFADFLSEEF
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.